Cancer is one of the largest and fastest-growing drivers of employer healthcare spend, fueled by late diagnoses, fragmented treatment care, and unmanaged survivorship. Color helps employers take control by addressing cancer earlier, managing it clinically across every stage, and preventing avoidable delays, complications, and downstream costs.

Color is designed to work with, not replace, an employer’s health plan. Care is integrated with in-network providers and existing benefit programs, allowing employers to add a clinically-led cancer program without disrupting current coverage or mandating sites of care.

Color delivers direct clinical cancer care. Our oncologist-led clinical team diagnoses, prescribes, orders tests, manages symptoms, and collaborates peer to peer with local, treating providers. This care goes beyond navigation, which can guide but cannot intervene clinically.

All eligible employees and covered family members and dependents can use Color, regardless of cancer type, stage, or where they are in the journey. This includes people focused on cancer screening, those newly diagnosed, individuals in active cancer treatment, and cancer survivors.

Color pairs clinical access with thoughtful, multi-channel engagement designed to meet and engage employees where they are. This approach consistently drives higher enrollment and use by reducing friction, fear, and confusion around cancer care screening, diagnosis and clinical treatment.

Employers receive clear reporting tied to member engagement with the benefit, clinical outcomes from using Color, and Color’s financial impact. Results include faster diagnosis, higher screening adherence, closed care gaps, and measurable cost savings, delivering strong return on investment (ROI) in year one. Color also delivers a 2.8:1 ROI in Year 1, backed by a 1:1 annual ROI guarantee.